Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.
Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Arkuda Therapeutics is a pharmaceutical company.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Tioga Cardiovascular is a healthcare company providing valve replacement solutions for mitral and tricuspid applications.
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.
Moximed develops innovative therapies for patients with knee osteoarthritis.
Adona Medical is a technology-based company that designs and develops heart failure management systems to improve heart care.
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.
Cormorant Asset Management has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 14 different industry categories.
Among tracked funding rounds, Akero Therapeutics received $366.9M in a Post-IPO Equity round. Cormorant Asset Management's total known invested capital is $23.5B.
Cormorant Asset Management's average investment size is $137.2M across its portfolio of 209 companies.
Recent Cormorant Asset Management portfolio additions include Orchard Therapeutics, Akero Therapeutics, OnKure Therapeutics, Stoke Therapeutics, Supira Medical. These companies were founded in 2020 or later.